RecruitingNCT03810768

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness

Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)


Sponsor

Technical University of Munich

Enrollment

20 participants

Start Date

Sep 2, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the metabolic changes that occur in critically ill patients who develop Intensive Care Unit-Acquired Muscle Weakness (ICUAW) — a condition where prolonged mechanical ventilation and immobility lead to significant muscle loss and weakness. By analyzing metabolites in patients' blood and muscle tissue, researchers aim to better understand why this happens and how to prevent it. You may be eligible if: - You are 18 years old or older - You have undergone surgery and are now in intensive care on a mechanical ventilator - Your ICU stay is expected to last more than 3 days - You have an ASA classification of III or higher (meaning you have serious systemic disease) You may NOT be eligible if: - You are considered a moribund patient (actively dying) - You are receiving comfort-only or palliative care rather than curative treatment Talk to your family or healthcare proxy about whether participation in this observational study aligns with your wishes during intensive care.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Medical University of Vienna

Vienna, State of Vienna, Austria

Klinikum rechts der Isar, School of Medicine, Technical University of Munich

Munich, Bavaria, Germany

Charité - Universitätsmedizin Berlin

Berlin, State of Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03810768


Related Trials